Onur Baser

Summary

Affiliation: Thomson Scientific
Country: UK

Publications

  1. ncbi Longitudinal analysis of censored medical cost data
    Onur Baser
    Thomson Medstat, Ann Arbor, MI 48108, USA
    Health Econ 15:513-25. 2006
  2. ncbi Guidelines for selecting among different types of bootstraps
    Onur Baser
    Outcomes Research and Econometrics, Thomson Medstat Group Inc, Ann Arbor, MI, USA
    Curr Med Res Opin 22:799-808. 2006
  3. ncbi Too much ado about propensity score models? Comparing methods of propensity score matching
    Onur Baser
    Thomson Medstat, Ann Arbor, MI, USA
    Value Health 9:377-85. 2006
  4. doi Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies
    Lin Xie
    STATinMED Research, Ann Arbor, MI 48104, USA
    J Med Econ 16:1137-45. 2013
  5. ncbi Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database
    Onur Baser
    Internal Medicine, Rheumatology Department, The University of Michigan, 211N 4th Avenue, Suite 2B, Ann Arbor, MI, 48104, USA
    Rheumatol Int 33:2577-84. 2013
  6. doi Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus
    Lin Xie
    STATinMED Research, Inc, Ann Arbor, MI, USA
    Diabetes Technol Ther 15:230-6. 2013
  7. ncbi Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs
    Onur Baser
    The University of Michigan, Ann Arbor, Ann Arbor, MI, USA
    Am J Manag Care 18:294-302. 2012
  8. doi Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry
    Onur Baser
    The University of Michigan, Ann Arbor, MI, USA
    Curr Med Res Opin 28:419-28. 2012
  9. doi A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
    Lin Xie
    STATinMED Research, 211 North Fourth Avenue, Suite 2B, Ann Arbor, MI, 48104, USA
    Adv Ther 28:1000-11. 2011
  10. pmc Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey
    Onur Baser
    Internal Medicine Department, Rheumatology Division, The University of Michigan, 211 N 4th Avenue, Suite 2B, Ann Arbor, MI 48104, USA
    Health Econ Rev 3:5. 2013

Detail Information

Publications20

  1. ncbi Longitudinal analysis of censored medical cost data
    Onur Baser
    Thomson Medstat, Ann Arbor, MI 48108, USA
    Health Econ 15:513-25. 2006
    ..The methods are applied to a sample of 201 Medicare beneficiaries diagnosed with lung cancer between 1994 and 1997...
  2. ncbi Guidelines for selecting among different types of bootstraps
    Onur Baser
    Outcomes Research and Econometrics, Thomson Medstat Group Inc, Ann Arbor, MI, USA
    Curr Med Res Opin 22:799-808. 2006
    ..Its success lies in the ease of estimating sampling distribution, standard error and confidence intervals with few or no assumptions about the distribution of the underlying population...
  3. ncbi Too much ado about propensity score models? Comparing methods of propensity score matching
    Onur Baser
    Thomson Medstat, Ann Arbor, MI, USA
    Value Health 9:377-85. 2006
    ..In this article we evaluate several matching techniques and provide a suggested guideline for selecting the best technique...
  4. doi Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies
    Lin Xie
    STATinMED Research, Ann Arbor, MI 48104, USA
    J Med Econ 16:1137-45. 2013
    ..To evaluate the real-world rates of hypoglycemia and related costs among patients with type 2 diabetes mellitus (T2DM) who initiated insulin glargine with either a disposable pen or vial-and-syringe...
  5. ncbi Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database
    Onur Baser
    Internal Medicine, Rheumatology Department, The University of Michigan, 211N 4th Avenue, Suite 2B, Ann Arbor, MI, 48104, USA
    Rheumatol Int 33:2577-84. 2013
    ..The significant portion of the annual costs was due to pharmaceutical expenditures. Comparative effectiveness analysis may be useful to decrease RA-related pharmacy costs...
  6. doi Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus
    Lin Xie
    STATinMED Research, Inc, Ann Arbor, MI, USA
    Diabetes Technol Ther 15:230-6. 2013
    ....
  7. ncbi Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs
    Onur Baser
    The University of Michigan, Ann Arbor, Ann Arbor, MI, USA
    Am J Manag Care 18:294-302. 2012
    ..To evaluate the real-world use of venous thromboembolism (VTE) prophylaxis among medical inpatients and the impact of VTE prophylaxis on outcomes and cost...
  8. doi Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry
    Onur Baser
    The University of Michigan, Ann Arbor, MI, USA
    Curr Med Res Opin 28:419-28. 2012
    ..Unique in its tumor aggression and high rates of recurrence, TNBC is less likely to be detected by mammogram and has a poorer prognosis than other breast cancer subtypes (non-TNBC)...
  9. doi A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
    Lin Xie
    STATinMED Research, 211 North Fourth Avenue, Suite 2B, Ann Arbor, MI, 48104, USA
    Adv Ther 28:1000-11. 2011
    ..Clinical and economic outcomes following initiation with insulin glargine disposable pen (GLA-P) or insulin detemir disposable pen (DET-P) in T2DM patients were compared over 1-year follow-up...
  10. pmc Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey
    Onur Baser
    Internal Medicine Department, Rheumatology Division, The University of Michigan, 211 N 4th Avenue, Suite 2B, Ann Arbor, MI 48104, USA
    Health Econ Rev 3:5. 2013
    ..This study aimed to apply the previously validated severity index for rheumatoid arthritis (SIFRA) to prevalent rheumatoid arthritis (RA) groups in Turkey and determine the effect of RA severity on health care costs and biologic use...
  11. doi High cost patients for cardiac surgery and hospital quality in Turkey
    Onur Baser
    The University of Michigan, Ann Arbor, USA
    Health Policy 109:143-9. 2013
    ..Encourage quality improvements and assess high expenditures for patients with coronary artery bypass graft (CABG) surgery and hospital quality in Turkey...
  12. doi Venous thromboembolism prophylaxis and clinical consequences in medically ill patients
    Onur Baser
    Internal Medicine, University of Michigan, Ann Arbor, MI 48104, USA
    Am J Ther 20:132-42. 2013
    ..27.95%, P < 0.02) during the 6 months post-index hospital admission. In conclusion anticoagulant prophylaxis is underutilized and is associated with reduced VTE risk and a decrease in rehospitalizations for medically ill patients...
  13. doi Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID
    Onur Baser
    The University of Michigan, MI, USA
    J Med Econ 14:673-80. 2011
    ..To evaluate clinical and economic outcomes in patients with type 2 diabetes mellitus (T2DM) who failed oral anti-diabetic drug (OAD) therapy and initiated either insulin glargine with disposable pen (GLA-P) or exenatide BID (EXE)...
  14. doi Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy
    Onur Baser
    The University of Michigan and STATinMED Research, Ann Arbor, MI 48104, USA
    J Med Econ 14:576-83. 2011
    ....
  15. pmc Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge
    Li Wang
    STATinMED Research and The University of Michigan, Ann Arbor, MI, USA
    Thromb J 9:15. 2011
    ..abstract:..
  16. doi Too much ado about instrumental variable approach: is the cure worse than the disease?
    Onur Baser
    STATinMED Research, LLC, 218 N Fourth Avenue, Ann Arbor, MI 48104, USA
    Value Health 12:1201-9. 2009
    ..In this article, we provide an overview of the IV approach, examine possible tests to check the prerequisite conditions, and illustrate how weak instruments may produce inconsistent and inefficient results...
  17. pmc Variations in the use of internal fixation for distal radial fracture in the United States medicare population
    Kevin C Chung
    Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, 2130 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0340, USA
    J Bone Joint Surg Am 93:2154-62. 2011
    ....
  18. doi Cost and clinical consequences of stress/single-photon emission computed tomography testing with specific medications
    Onur Baser
    STATinMED Research, 211 N 4th Avenue, Ann Arbor, MI 48104, USA
    J Med Econ 14:433-9. 2011
    ..We identified the cost of care and clinical events using dipyridamole versus adenosine in pharmacological stress (ST)/single-photon-emission computed tomography (SPECT) myocardial perfusion testing...
  19. ncbi Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty
    Onur Baser
    University of Michigan, STATinMED Research, Ann Arbor, MI 48104, USA
    Am J Manag Care 17:S6-8. 2011
    ..Prevention of VTE would improve patient outcomes and result in substantial savings to payers and providers...
  20. doi Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery
    Onur Baser
    The University of Michigan Arbor, MI, USA
    Curr Med Res Opin 27:423-9. 2011
    ..Since the potential for VTE exists in a range of clinical settings, an assessment of its impact on overall outcomes and costs to the patient and to the healthcare system is warranted...